TP53 and non-small cell lung carcinoma: Research utilizing next-generation sequencing (NGS) to examine NSCLC patients who later developed SCLC found that TP53 C176S and EGFR exon 19 deletions were present in consecutive biopsy samples and varied in a parallel manner.